NCT00241423 Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00240357 Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia Status WITHDRAWN Phase PHASE4
NCT00240344 Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal Status COMPLETED Phase N/A
NCT00240331 AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD) Status COMPLETED Phase PHASE3
NCT00240318 A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID) Status COMPLETED Phase PHASE3
NCT00240305 A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome Status COMPLETED Phase PHASE3
NCT00240292 Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines Status COMPLETED Phase PHASE3
NCT00240279 The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study Status COMPLETED Phase PHASE3
NCT00240266 Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT) Status COMPLETED Phase PHASE3
NCT00240253 A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00239681 JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events Status TERMINATED Phase PHASE3
NCT00239343 Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer Status COMPLETED Phase PHASE2
NCT00239330 Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy Status COMPLETED Phase PHASE3
NCT00239304 Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00239291 Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00239278 Budesonide / Formoterol in Treatment of Exacerbations of COPD Status COMPLETED Phase PHASE2
NCT00238797 A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00238784 SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults Status COMPLETED Phase PHASE3
NCT00238628 A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2